The role of mucosal antiviral immunity in bacterial secondary lung infections  by Metzger, D.
e th In
B
s
4
S
i
J
b
t
c
e
t
w
n
v
o
m
v
b
b
t
w
t
s
h
n
p
a
H
t
d
4
T
o
D
m
w
f
W
l
i
a
d
i
a
l
d
w
m
a
r
b
c
i
a
d
4
A
b
T
m
T
s
m
‘
a
p
i
c
i
i
1
t
m
a
m
i
t
s
(
R
t
d
r
p
v
d
4
L
r
K
r
i
h
v
o
p182 14
acterial infections following inﬂuenza (Invited Pre-
entation)
4.001
econdary bacterial infections - The other side of
nﬂuenza pathogenesis
. McCullers
St. Jude Children’s Research Hospital, Memphis, TN, USA
Secondary bacterial infections are a major cause of mor-
idity and mortality following inﬂuenza. This was especially
rue during past pandemics, where 50-95% of all deaths were
omplicated by or attributed to bacterial pathogens. The
mergence in 2009 of a new pandemic strain has increased
he urgency for us to understand how bacteria work together
ith inﬂuenza viruses to cause pneumonia. Several mecha-
isms have been postulated to explain this interaction. The
iral neuraminidase has been shown to enhance adherence
f bacteria and increase the incidence of bacterial pneu-
onia. The lack of glycosylation of the surface proteins of
iruses emerging from the avian reservoir contributes to
oth primary virulence and secondary bacterial infections
y preventing viral clearance. Recent work has implicated
he inﬂuenza A virus protein PB1-F2 as a virulence factor
hich enhances secondary bacterial pneumonia. Although
he novel H1N1 swine-origin inﬂuenza virus has molecular
ignatures that predict viral virulence in humans including
igh neuraminidase activity and low glycosyltation, it does
ot possess a functional PB1-F2 protein. In the context of a
andemic, it is likely that secondary bacterial complications
nd overall mortality will be lower because of this absence.
owever, reassortment or mutation to restore PB1-F2 func-
ion to this virus could herald greatly expanded virulence.
oi:10.1016/j.ijid.2010.02.1890
4.002
he role of mucosal antiviral immunity in bacterial sec-
ndary lung infections
. Metzger
Albany Medical College, Albany, NY, USA
Bacterial co-infections are typically a major cause of
ortality following inﬂuenza infection, including infection
ith the pandemic H1N1 Cal/04/09 virus, but the reason
or this increased susceptibility is only poorly understood.
e have found that alveolar macrophages are the ﬁrst
ine of defense against pulmonary pneumococcal and MRSA
nfection, and can very rapidly (within 4 hr) clear almost
ll bacteria after in vivo challenge with a relatively low
ose (up to 105 CFU of pneumococci). However, prior
nﬂuenza virus infection inhibits this clearance mechanism
nd causes normally sublethal doses of bacteria to be 100%
ethal. This is due to production of interferon (IFN)-gamma
uring pulmonary T cell responses to inﬂuenza infection,
hich inhibits scavenger receptor expression by alveolar
acrophages and in turn, leads to decreased bacterial clear-
nce from the lung. Thus, the increased anti-viral immune
esponse causes decreased protection against pulmonary
acterial infection. These results and the potential of vac-
t
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i
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ination to induce protection against secondary bacterial
nfections will be discussed in the context of both seasonal
nd H1N1 inﬂuenza infection.
oi:10.1016/j.ijid.2010.02.1891
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lteration of the Innate Immune Rheostat and Suscepti-
ility to Secondary Bacterial Superinfections
. Hussell
National Heart and Lung Institute, London, United Kingdom
Infection of mucosal surfaces culminates in long term
odiﬁcations that impact on future inﬂammatory events.
hese modiﬁcations do not necessarily depend on per-
istence of the original pathogen but on the altered
icroenvironment which occurs upon resolution. This
‘imprinting’’ by the ﬁrst pathogen involves subtle alter-
tions of epithelial cells, resident mucosal macrophages,
roduction of mediators that recruit immune cells and
mportantly, an alteration in the local microbial commensal
ommunity.
Bacterial super-infections are common following
nﬂuenza and lead to a worse prognosis often resulting
n death. Analysis of post-mortem specimens from the
918-19 pandemic shows a bacterial prevalence greater
han 95%. Control of initial bacterial growth relies on
ultiple components of innate immunity, many of which
re disrupted following inﬂuenza virus infection in murine
odels. One key determinant that limits bacterial growth
s the responsiveness of airway macrophages to bacteria in
he airspaces. We show that inﬂuenza virus limits respon-
iveness by enhancing an innate immune negative regulator
CD200 receptor) during resolution of adaptive immunity.
emoval of this single receptor limits bacterial burden in
he airway and lung and completely prevents peripheral
issemination, sepsis and mortality. Adjustment of innate
eactivity may therefore provide a novel opportunity to
revent life-threatening consequences of lung inﬂuenza
irus infection.
oi:10.1016/j.ijid.2010.02.1892
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essons from 1918 and the current H1N1 pandemic on the
ole of bacterial infections during pandemic inﬂuenza
. Klugman
Emory University, Atlanta, GA, USA
The current pandemic of H1N1 inﬂuenza has features
eminiscent of 1918 including infections and excess morbid-
ty in young adults. The impact in terms of mortality has
owever been far less severe. This is in part due to lesser
irulence of the virus, but also to the introduction of antibi-
tics and most recently to the introduction of conjugate
neumococcal vaccines in some countries that have reduced
he morbidity of inﬂuenza associated pneumonia. During the
918 pandemic, post mortem data suggest that the major-
ty of deaths were associated with bacterial superinfection
eading to pneumonia following 4 - 6 days after inﬂuenza. A
